VeriTeQ’s U.S. Food and Drug Administration (FDA)-cleared Q Inside Safety Technology acts as an electronic serial number in breast implants and other implantable and reusable medical devices. By including VeriTeQ’s Q Inside Safety Technology in Motiva Implant Matrix implants, manufacturers, physicians and patients have access to a secure online database to retrieve implant-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. Q Inside Safety Technology also provides an extra level of protection to the patient in the event of a recall or other safety event, the company notes.
Motiva’s SilkSurface PLUS implants provide a soft, gliding printed nano-surface that reduces complications related to traditional textures while reducing capsular contracture rates. Motiva’s VelvetSurface PLUS implants provide a printed micro-surface that promotes a more secure fit in the breast pocket.
“We continue to advance the safety and exclusivity of our entire breast implant portfolio to answer the demands from both physicians and patients alike,” said Juan José Chacón-Quirós, CEO of Establishment Labs. “Including VeriTeQ’s Q Inside Safety Technology in Motiva’s SilkSurface PLUS and VelvetSurface PLUS implants emphasizes our primary focus of providing products for the protection of the patient.”
Scott R. Silverman, Chairman and CEO of VeriTeQ, added, “We believe these new CE Mark approvals will provide continued momentum for EL’s product launch in the EU [European Union]. Giving physicians and patients the power to identify their breast implants in a healthcare setting is the next generation of technology and security, and we believe both groups will ultimately demand this level of safety from their implants.”
According to the International Society of Aesthetic Plastic Surgery, the number of breast augmentation procedures performed worldwide in 2011 exceeded 1.2 million.
Establishment Labs is a privately held, global breast, body and facial aesthetic company with offices in Florida, Costa Rica and Belgium that designs, develops, manufactures and markets silicone-filled breast and body-shaping implants. Its products are certified under the Medical Device Directive 93/42/EEC.
Based in Delray Beach, Fla., VeriTeQ develops proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ's FDA-approved RFID microchip technology can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time.